Pfizer Says It Shouldn't Be Included In EpiPen Class Cert. Bid
Pfizer is fighting to keep a Kansas federal judge from certifying five classes of consumers who say the pharmaceutical giant had a hand in delaying the entry of a generic version...To view the full article, register now.
Already a subscriber? Click here to view full article